510(k) K211334— Iovera System

Substantially Equivalent

Pacira Pharmaceuticals, Inc.

Clearance details

Applicant: Pacira Pharmaceuticals, Inc.
Product code: Code GXH
Advisory panel: Neurology
Date received: 2021-05-03
Decision date: 2021-09-10
Decision: Substantially Equivalent
Clearance type: Special
Location: Fremont, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.